SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Lexeo Therapeutics to host educational event on PKP2-ACM clinical endpoints

The company will host an educational event focused on clinical endpoints and outcome measures in PKP2-ACM.

LXEO